A nurse is providing education to a group of clients with phobias. The nurse explains that exposure therapy involves gradual and repeated exposure to the feared object or situation in a controlled manner until the fear diminishes. Which of the following statements accurately describes exposure therapy?

Choice A rationale:

Antipsychotics are not commonly prescribed to manage anxiety and fear associated with phobias. Antipsychotics are primarily used to treat psychotic disorders, such as schizophrenia, and are not the first-line treatment for anxiety-related disorders.

Choice B rationale:

Antihistamines are not commonly prescribed for managing anxiety and fear associated with phobias. While some sedating antihistamines might have a calming effect, they are not the primary choice for treating anxiety. Antihistamines are more commonly used for allergies and sleep disturbances.

Choice C rationale:

Anticonvulsants are not typically prescribed for managing anxiety and fear associated with phobias. Anticonvulsants are used to treat conditions such as epilepsy and mood disorders like bipolar disorder, but they are not the first-line treatment for specific phobias.

Choice D rationale:

Antidepressants are commonly prescribed to manage anxiety and fear associated with phobias. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used antidepressants that can effectively reduce the symptoms of anxiety and phobias by influencing neurotransmitter levels in the brain. These medications help regulate mood and reduce excessive anxiety associated with phobias.

Choice A rationale:

Antidepressants (Choice A) are not typically the first-line medication class for treating specific phobias. While they may be used in some cases, they are not the primary choice for addressing the symptoms of phobias.

Choice B rationale:

Benzodiazepines (Choice B) are sometimes used to manage acute anxiety symptoms, but they are generally not recommended for long-term treatment of specific phobias due to the risk of dependence and potential side effects.

Choice C rationale:

Beta-blockers (Choice C) can be useful in managing the physical symptoms of anxiety, such as rapid heartbeat and trembling, which often accompany phobias. They work by blocking the effects of adrenaline, reducing the "fight or flight" response. This can help the client feel more physically at ease when confronting their phobic stimulus.

Choice D rationale:

Analgesics (Choice D) are pain-relieving medications and have no direct relevance to treating phobias. They do not address the underlying fear and anxiety associated with phobias.